Mallinckrodt Plc (NYSE:MNK)

16.50
Delayed Data
As of May 25
 +0.06 / +0.36%
Today’s Change
11.65
Today|||52-Week Range
49.12
-26.86%
Year-to-Date

Today’s Trading

Previous close16.44
Today’s open16.36
Day’s range16.28 - 16.59
Volume1,694,767
Average volume (3 months)3,798,910
Market cap$1.3B
Data as of 4:02pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+268.38%
Earnings growth (this year)-16.70%
Earnings growth (next 5 years)-1.00%
Revenue growth (last year)-4.71%
P/E ratio1.0
Price/Sales0.69
Price/Book0.21

Competitors

----
AKRXAkorn Inc+0.07+0.50%
PBYIPuma Biotechnology I...+0.30+0.58%
OPKOPKO Health Inc0.000.00%
Data as of 4:15pm ET, 05/25/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$1.54
Annual revenue (last year)$3.2B
Annual profit (last year)$1.8B
Net profit margin54.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
EVP-Global Operations &
Digital Innovation Officer
Frank Scholz
Corporate headquarters
Staines-Upon-Thames, Surrey

Forecasts